Drexel University College of Medicine's clinical research program seeks to improve patient care through innovative approaches and new findings. By evaluating medicines, therapies and diagnostic tools, clinical research drives discoveries in health promotion and disease prevention to improve health.
Research Projects Involving Human Subjects Contingency Planning
To ensure safety of our researchers, staff, and research participants and to be aligned with the most recent NIH guidance, the Office of Research & Innovation is requesting that research involving person-to-person contact or gatherings of human research participants be paused as soon as possible unless needed for participant safety. Learn more.
Many biomedical and social-behavioral research studies require the participation of human volunteers. These studies must be reviewed by a committee called an Institutional Review Board (IRB). The IRB is made up of at least 5 members from diverse backgrounds including scientific and nonscientific professionals as well representatives from various communities not affiliated with Drexel. The IRB helps to ensure the safety of research participants and to ensure ethical standards required by Federal regulation, international best practices, state and local laws, as well as institutional policies are met. Learn more.
Announcement: Updated Clinical Trials Indirect Rate
In follow up to a review of current indirect costs of industry sponsored clinical trials/research, the Office of Research in coordination with College of Medicine and Research Accounting Services has agreed upon a 35% rate for indirect costs for all industry sponsored clinical trials/research. This change is retroactively effective to April 1, 2021. If you have any questions, please do not hesitate to contact firstname.lastname@example.org or Maria T. Schulthies, PhD (email@example.com) or Aleister J. Saunders, PhD (firstname.lastname@example.org) directly.
Research Solutions Committee for Clinical Research
The Office of the Senior Vice Dean for Research is launching a Research Solutions Committee. The goal is to give clinical researchers an opportunity to address concerns and issues with their clinical research projects. Learn more.
Open Clinical Trials
HOPE in ACTION: The HOPE in ACTION Clinical Trial is an NIH study looking at outcomes of HIV+ kidney transplant recipients who may receive either a kidney from a HIV+ donor or an HIV- donor. Learn more.
Clinical trials are research studies involving human participants that evaluate a new medical approach, device, drug or other treatment. They are performed with people who have volunteered to help answer a specific health question. For example, a clinical trial might determine whether a certain drug or treatment prevents a certain disease or condition. Learn more.
Back to Top